German device industry demands DRG (Diagnosis Related Groups) system clarity
This article was originally published in Clinica
Executive Summary
Transparency and flexibility must be paramount if the DRG (Diagnosis Related Groups) system is to be a success, claims the German industry association for medical devices (BVMed). In a letter written in response to the government's "draft law on the introduction of the DRG system for hospitals", BVMed said that the system must remain flexible so that innovative products could be included and the "holes which will inevitably appear during the introductory stages of the flat-rate reimbursement catalogue can be appropriately filled".
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.